Cargando…

Monocyte Chemoattractant Protein-1-Deficiency Impairs the Expression of IL-6, IL-1β and G-CSF after Transient Focal Ischemia in Mice

Monocyte chemoattractant protein-1 (MCP-1), a chemokine secreted by neurons and astrocytes following stroke is known to aggravate ischemia-related damage. Previous studies revealed that MCP-1-deficient mice develop smaller infarcts and have an improved neurological outcome, whereas mice overexpressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strecker, Jan-Kolja, Minnerup, Jens, Gess, Burkhard, Ringelstein, E. Bernd, Schäbitz, Wolf-Rüdiger, Schilling, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198727/ https://www.ncbi.nlm.nih.gov/pubmed/22031820 http://dx.doi.org/10.1371/journal.pone.0025863

Ejemplares similares

Sodium-Dependent Vitamin C Transporter 2 (SVCT2) Expression and Activity in Brain Capillary Endothelial Cells after Transient Ischemia in Mice
por: Gess, Burkhard, et al.
Publicado: (2011)

Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats
por: Diederich, Kai, et al.
Publicado: (2014)

Photochemically induced ischemic stroke in rats
por: Schmidt, Antje, et al.
Publicado: (2012)

Effects of Different Exercise Strategies and Intensities on Memory Performance and Neurogenesis
por: Diederich, Kai, et al.
Publicado: (2017)

Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats
por: Minnerup, Jens, et al.
Publicado: (2014)

Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success
por: Minnerup, Jens, et al.
Publicado: (2014)

Role of monocyte chemoattractant protein‐1 in liver fibrosis with transient myeloproliferative disorder in down syndrome
por: Kobayashi, Kenichiro, et al.
Publicado: (2018)

Functional Improvement after Photothrombotic Stroke in Rats Is Associated with Different Patterns of Dendritic Plasticity after G-CSF Treatment and G-CSF Treatment Combined with Concomitant or Sequential Constraint-Induced Movement Therapy
por: Frauenknecht, Katrin, et al.
Publicado: (2016)

Sphingosine 1-Phosphate Induces Neutrophil Chemoattractant IL-8: Repression by Steroids
por: Rahman, Md. Mostafizur, et al.
Publicado: (2014)

Fibroblasts Promote Inflammation and Pain via IL-1α Induction of the Monocyte Chemoattractant Chemokine (C-C Motif) Ligand 2
por: Paish, Hannah L., et al.
Publicado: (2018)

Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia
por: Minnerup, Jens, et al.
Publicado: (2010)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Immune Cell Infiltration into the Brain After Ischemic Stroke in Humans Compared to Mice and Rats: a Systematic Review and Meta-Analysis
por: Beuker, Carolin, et al.
Publicado: (2021)

IL-1 production as a regulator of G-CSF and IL-6 production in CSF-producing cell lines.
por: Suzuki, A., et al.
Publicado: (1992)

IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression
por: Casella, Giacomo, et al.
Publicado: (2017)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

EPO for stroke therapy - Is there a future for further clinical development?
por: Minnerup, Jens, et al.
Publicado: (2010)

Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies
por: Minnerup, Jens, et al.
Publicado: (2009)

Erythropoietin for stroke treatment: dead or alive?
por: Minnerup, Jens, et al.
Publicado: (2011)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

An extended window of opportunity for G-CSF treatment in cerebral ischemia
por: Schneider, Armin, et al.
Publicado: (2006)

CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosis
por: Panigrahi, Soumya, et al.
Publicado: (2020)

GM-CSF Signalling Boosts Dramatically IL-1Production
por: Khameneh, Hanif Javanmard, et al.
Publicado: (2011)

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
por: Blondy, Thibaut, et al.
Publicado: (2020)

Induction of M-MDSCs with IL6/GM-CSF from adherence monocytes and inhibition by WP1066
por: Hu, Hao, et al.
Publicado: (2022)

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease
por: Porcellini, Elisa, et al.
Publicado: (2013)

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
por: Radhakrishnan, Preethi, et al.
Publicado: (2014)

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
por: Lim, Jun Pei, et al.
Publicado: (2015)

Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy
por: Wyler, Stephanie L., et al.
Publicado: (2016)

CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2017)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Deficiency for the Chemokine Monocyte Chemoattractant Protein-1 Aggravates Tubular Damage after Renal Ischemia/Reperfusion Injury
por: Stroo, Ingrid, et al.
Publicado: (2015)

Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer
por: Lin, WeiYu, et al.
Publicado: (2019)

IL-3 and CSF-1 Interact to Promote Generation of CD11c(+) IL-10-Producing Macrophages
por: Sheng, Kuo-Ching, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c9pk7e52ou4ssos1t9ek4tsrll